0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transcutaneous Jaundice Device Market Research Report 2026
Published Date: 2025-12-31
|
Report Code: QYRE-Auto-32V13299
Home | Market Reports | Health| Medical Devices & Equipment
Global Transcutaneous Jaundice Device Market Research Report 2023
BUY CHAPTERS

Global Transcutaneous Jaundice Device Market Research Report 2026

Code: QYRE-Auto-32V13299
Report
2025-12-31
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transcutaneous Jaundice Device Market Size

The global Transcutaneous Jaundice Device market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.

Transcutaneous Jaundice Device Market

Transcutaneous Jaundice Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Transcutaneous Jaundice Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Transcutaneous Jaundice Device reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Transcutaneous Jaundice Device are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Transcutaneous Jaundice Device mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Transcutaneous Jaundice Device varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
Transcutaneous Jaundice Device are non-invasive sentinels protecting newborn health. Designed specifically for neonatal jaundice screening, these medical devices utilize spectral absorption technology. Simply place the probe lightly against the infant's forehead or sternum, and within seconds, the difference in reflection between blue and green light is used to calculate bilirubin levels, completely eliminating the pain and waiting associated with traditional blood tests. From bedside screening in maternity wards to routine monitoring in primary care hospitals and home follow-up, this device, with its non-invasive, rapid, and safe characteristics, has become a key tool for the early detection and intervention of neonatal hyperbilirubinemia, building the first line of defense for the health of millions of newborns worldwide.
The global market for Transcutaneous Jaundice Device exhibits a distinct regional development pattern. North America, relying on its mature neonatal healthcare system and high medical investment, has stable and concentrated market demand. Local companies have accumulated deep expertise in device intelligence and clinical adaptability, occupying a core position in the global market. Europe excels in technological precision, with stringent medical standards driving equipment upgrades towards low-interference, high-precision solutions. Products not only serve the well-developed local healthcare network but also radiate globally through technology exports. The Asia-Pacific region has become the core engine of industry growth. China, with its large newborn population and policies promoting the widespread availability of basic medical equipment, has propelled domestic brands from followers to leaders. Meanwhile, emerging markets such as India and Southeast Asia, with their improving healthcare infrastructure, are releasing strong incremental demand. According to our data, in 2024, Asia held nearly 50% of the market share for Transcutaneous Jaundice Device, followed by Europe and North America. During the forecast period, emerging markets such as India and Southeast Asia are leading the global growth rate.
From a manufacturer perspective, globally, key manufacturers of Transcutaneous Jaundice Device include Dräger, Mennen Medical, Philips, Konica Minolta, Beijing Maibang Optoelectronics, Ningbo Davy Medical, Weicai, AVI Healthcare, NEORUBIN (RECOVE GROUP), Nanjing Daofen Electronics, Likang Biotechnology, Boke Biotechnology, and Micro Lab. According to our data, the top 5 manufacturers accounted for over 70% of the global market share in 2024.
The convergence of multiple demands and policies has injected continuous growth momentum into the Transcutaneous Jaundice Device industry. The high incidence of neonatal jaundice forms a rigid demand foundation, while the monitoring needs of premature and high-risk infants further make the equipment a clinical necessity. At the policy level, countries are incorporating neonatal disease screening into their public health systems, while technological innovation is reshaping product value. Multi-wavelength spectral technology overcomes the bottleneck of skin color interference, and intelligent algorithms enable real-time data transmission and trend prediction, upgrading the equipment from a simple testing tool to an entry point for neonatal health management. Meanwhile, the public's growing preference for non-invasive medical care and increased awareness of home health monitoring have further broadened application scenarios, extending from hospitals to homes and forming a full-cycle monitoring ecosystem.
This report delivers a comprehensive overview of the global Transcutaneous Jaundice Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transcutaneous Jaundice Device. The Transcutaneous Jaundice Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Transcutaneous Jaundice Device market comprehensively. Regional market sizes by Type, by Application, by Technology, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Transcutaneous Jaundice Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Transcutaneous Jaundice Device Market Report

Report Metric Details
Report Name Transcutaneous Jaundice Device Market
Accounted market size in 2025 US$ 105 million
Forecasted market size in 2032 US$ 113 million
CAGR 1.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Standard Type
  • Intelligent Type
Segment by Technology
  • Single Measurement Optical Path
  • Dual Measurement Optical Path
Segment by Power Supply
  • Rechargeable Type
  • Non-rechargeable Type
by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dräger, Mennen Medical, Philips, Konica Minolta, Beijing M&B Electronic Instruments, Ningbo David Medical Device, VECH MEDICAL, AVI Healthcare, NEORUBIN (RECOVE GROUP), Dolphin Nanjing electronics, Heal Force, BIOBASE GROUP, Micro Lab
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Transcutaneous Jaundice Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Transcutaneous Jaundice Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Transcutaneous Jaundice Device Market growing?

Ans: The Transcutaneous Jaundice Device Market witnessing a CAGR of 1.3% during the forecast period 2026-2032.

What is the Transcutaneous Jaundice Device Market size in 2032?

Ans: The Transcutaneous Jaundice Device Market size in 2032 will be US$ 113 million.

What is the market share of major companies in Transcutaneous Jaundice Device Market?

Ans: According to our data, the top 5 manufacturers accounted for over 70% of the global market share in 2024.

Who are the main players in the Transcutaneous Jaundice Device Market report?

Ans: The main players in the Transcutaneous Jaundice Device Market are Dräger, Mennen Medical, Philips, Konica Minolta, Beijing M&B Electronic Instruments, Ningbo David Medical Device, VECH MEDICAL, AVI Healthcare, NEORUBIN (RECOVE GROUP), Dolphin Nanjing electronics, Heal Force, BIOBASE GROUP, Micro Lab

What are the Application segmentation covered in the Transcutaneous Jaundice Device Market report?

Ans: The Applications covered in the Transcutaneous Jaundice Device Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Transcutaneous Jaundice Device Market report?

Ans: The Types covered in the Transcutaneous Jaundice Device Market report are Standard Type, Intelligent Type

1 Transcutaneous Jaundice Device Market Overview
1.1 Product Definition
1.2 Transcutaneous Jaundice Device by Type
1.2.1 Global Transcutaneous Jaundice Device Market Value by Type: 2025 vs 2032
1.2.2 Standard Type
1.2.3 Intelligent Type
1.3 Transcutaneous Jaundice Device by Technology
1.3.1 Global Transcutaneous Jaundice Device Market Value by Technology: 2025 vs 2032
1.3.2 Single Measurement Optical Path
1.3.3 Dual Measurement Optical Path
1.4 Transcutaneous Jaundice Device by Power Supply
1.4.1 Global Transcutaneous Jaundice Device Market Value by Power Supply: 2025 vs 2032
1.4.2 Rechargeable Type
1.4.3 Non-rechargeable Type
1.5 Transcutaneous Jaundice Device by Application
1.5.1 Global Transcutaneous Jaundice Device Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Global Transcutaneous Jaundice Device Market Size Estimates and Forecasts
1.6.1 Global Transcutaneous Jaundice Device Revenue 2021–2032
1.6.2 Global Transcutaneous Jaundice Device Sales 2021–2032
1.6.3 Global Transcutaneous Jaundice Device Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Transcutaneous Jaundice Device Market Competition by Manufacturers
2.1 Global Transcutaneous Jaundice Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Transcutaneous Jaundice Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Transcutaneous Jaundice Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Transcutaneous Jaundice Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Transcutaneous Jaundice Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Transcutaneous Jaundice Device, Product Types and Applications
2.7 Global Key Manufacturers of Transcutaneous Jaundice Device, Date of Entry into the Industry
2.8 Global Transcutaneous Jaundice Device Market Competitive Situation and Trends
2.8.1 Global Transcutaneous Jaundice Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Transcutaneous Jaundice Device Players Market Share by Revenue
2.8.3 Global Transcutaneous Jaundice Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transcutaneous Jaundice Device Market Scenario by Region
3.1 Global Transcutaneous Jaundice Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Transcutaneous Jaundice Device Sales by Region: 2021–2032
3.2.1 Global Transcutaneous Jaundice Device Sales by Region: 2021–2026
3.2.2 Global Transcutaneous Jaundice Device Sales by Region: 2027–2032
3.3 Global Transcutaneous Jaundice Device Revenue by Region: 2021–2032
3.3.1 Global Transcutaneous Jaundice Device Revenue by Region: 2021–2026
3.3.2 Global Transcutaneous Jaundice Device Revenue by Region: 2027–2032
3.4 North America Transcutaneous Jaundice Device Market Facts & Figures by Country
3.4.1 North America Transcutaneous Jaundice Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Transcutaneous Jaundice Device Sales by Country (2021–2032)
3.4.3 North America Transcutaneous Jaundice Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transcutaneous Jaundice Device Market Facts & Figures by Country
3.5.1 Europe Transcutaneous Jaundice Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Transcutaneous Jaundice Device Sales by Country (2021–2032)
3.5.3 Europe Transcutaneous Jaundice Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transcutaneous Jaundice Device Market Facts & Figures by Region
3.6.1 Asia Pacific Transcutaneous Jaundice Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Transcutaneous Jaundice Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Transcutaneous Jaundice Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Transcutaneous Jaundice Device Market Facts & Figures by Country
3.7.1 Latin America Transcutaneous Jaundice Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Transcutaneous Jaundice Device Sales by Country (2021–2032)
3.7.3 Latin America Transcutaneous Jaundice Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transcutaneous Jaundice Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Transcutaneous Jaundice Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Transcutaneous Jaundice Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Transcutaneous Jaundice Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transcutaneous Jaundice Device Sales by Type (2021–2032)
4.1.1 Global Transcutaneous Jaundice Device Sales by Type (2021–2026)
4.1.2 Global Transcutaneous Jaundice Device Sales by Type (2027–2032)
4.1.3 Global Transcutaneous Jaundice Device Sales Market Share by Type (2021–2032)
4.2 Global Transcutaneous Jaundice Device Revenue by Type (2021–2032)
4.2.1 Global Transcutaneous Jaundice Device Revenue by Type (2021–2026)
4.2.2 Global Transcutaneous Jaundice Device Revenue by Type (2027–2032)
4.2.3 Global Transcutaneous Jaundice Device Revenue Market Share by Type (2021–2032)
4.3 Global Transcutaneous Jaundice Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Transcutaneous Jaundice Device Sales by Application (2021–2032)
5.1.1 Global Transcutaneous Jaundice Device Sales by Application (2021–2026)
5.1.2 Global Transcutaneous Jaundice Device Sales by Application (2027–2032)
5.1.3 Global Transcutaneous Jaundice Device Sales Market Share by Application (2021–2032)
5.2 Global Transcutaneous Jaundice Device Revenue by Application (2021–2032)
5.2.1 Global Transcutaneous Jaundice Device Revenue by Application (2021–2026)
5.2.2 Global Transcutaneous Jaundice Device Revenue by Application (2027–2032)
5.2.3 Global Transcutaneous Jaundice Device Revenue Market Share by Application (2021–2032)
5.3 Global Transcutaneous Jaundice Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Dräger
6.1.1 Dräger Company Information
6.1.2 Dräger Description and Business Overview
6.1.3 Dräger Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Dräger Transcutaneous Jaundice Device Product Portfolio
6.1.5 Dräger Recent Developments/Updates
6.2 Mennen Medical
6.2.1 Mennen Medical Company Information
6.2.2 Mennen Medical Description and Business Overview
6.2.3 Mennen Medical Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mennen Medical Transcutaneous Jaundice Device Product Portfolio
6.2.5 Mennen Medical Recent Developments/Updates
6.3 Philips
6.3.1 Philips Company Information
6.3.2 Philips Description and Business Overview
6.3.3 Philips Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Philips Transcutaneous Jaundice Device Product Portfolio
6.3.5 Philips Recent Developments/Updates
6.4 Konica Minolta
6.4.1 Konica Minolta Company Information
6.4.2 Konica Minolta Description and Business Overview
6.4.3 Konica Minolta Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Konica Minolta Transcutaneous Jaundice Device Product Portfolio
6.4.5 Konica Minolta Recent Developments/Updates
6.5 Beijing M&B Electronic Instruments
6.5.1 Beijing M&B Electronic Instruments Company Information
6.5.2 Beijing M&B Electronic Instruments Description and Business Overview
6.5.3 Beijing M&B Electronic Instruments Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Beijing M&B Electronic Instruments Transcutaneous Jaundice Device Product Portfolio
6.5.5 Beijing M&B Electronic Instruments Recent Developments/Updates
6.6 Ningbo David Medical Device
6.6.1 Ningbo David Medical Device Company Information
6.6.2 Ningbo David Medical Device Description and Business Overview
6.6.3 Ningbo David Medical Device Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ningbo David Medical Device Transcutaneous Jaundice Device Product Portfolio
6.6.5 Ningbo David Medical Device Recent Developments/Updates
6.7 VECH MEDICAL
6.7.1 VECH MEDICAL Company Information
6.7.2 VECH MEDICAL Description and Business Overview
6.7.3 VECH MEDICAL Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 VECH MEDICAL Transcutaneous Jaundice Device Product Portfolio
6.7.5 VECH MEDICAL Recent Developments/Updates
6.8 AVI Healthcare
6.8.1 AVI Healthcare Company Information
6.8.2 AVI Healthcare Description and Business Overview
6.8.3 AVI Healthcare Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 AVI Healthcare Transcutaneous Jaundice Device Product Portfolio
6.8.5 AVI Healthcare Recent Developments/Updates
6.9 NEORUBIN (RECOVE GROUP)
6.9.1 NEORUBIN (RECOVE GROUP) Company Information
6.9.2 NEORUBIN (RECOVE GROUP) Description and Business Overview
6.9.3 NEORUBIN (RECOVE GROUP) Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 NEORUBIN (RECOVE GROUP) Transcutaneous Jaundice Device Product Portfolio
6.9.5 NEORUBIN (RECOVE GROUP) Recent Developments/Updates
6.10 Dolphin Nanjing electronics
6.10.1 Dolphin Nanjing electronics Company Information
6.10.2 Dolphin Nanjing electronics Description and Business Overview
6.10.3 Dolphin Nanjing electronics Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dolphin Nanjing electronics Transcutaneous Jaundice Device Product Portfolio
6.10.5 Dolphin Nanjing electronics Recent Developments/Updates
6.11 Heal Force
6.11.1 Heal Force Company Information
6.11.2 Heal Force Description and Business Overview
6.11.3 Heal Force Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Heal Force Transcutaneous Jaundice Device Product Portfolio
6.11.5 Heal Force Recent Developments/Updates
6.12 BIOBASE GROUP
6.12.1 BIOBASE GROUP Company Information
6.12.2 BIOBASE GROUP Description and Business Overview
6.12.3 BIOBASE GROUP Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 BIOBASE GROUP Transcutaneous Jaundice Device Product Portfolio
6.12.5 BIOBASE GROUP Recent Developments/Updates
6.13 Micro Lab
6.13.1 Micro Lab Company Information
6.13.2 Micro Lab Description and Business Overview
6.13.3 Micro Lab Transcutaneous Jaundice Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Micro Lab Transcutaneous Jaundice Device Product Portfolio
6.13.5 Micro Lab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transcutaneous Jaundice Device Industry Chain Analysis
7.2 Transcutaneous Jaundice Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transcutaneous Jaundice Device Production Mode & Process Analysis
7.4 Transcutaneous Jaundice Device Sales and Marketing
7.4.1 Transcutaneous Jaundice Device Sales Channels
7.4.2 Transcutaneous Jaundice Device Distributors
7.5 Transcutaneous Jaundice Device Customer Analysis
8 Transcutaneous Jaundice Device Market Dynamics
8.1 Transcutaneous Jaundice Device Industry Trends
8.2 Transcutaneous Jaundice Device Market Drivers
8.3 Transcutaneous Jaundice Device Market Challenges
8.4 Transcutaneous Jaundice Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Transcutaneous Jaundice Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Transcutaneous Jaundice Device Market Value by Technology (US$ Million), 2025 vs 2032
 Table 3. Global Transcutaneous Jaundice Device Market Value by Power Supply (US$ Million), 2025 vs 2032
 Table 4. Global Transcutaneous Jaundice Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Transcutaneous Jaundice Device Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Transcutaneous Jaundice Device Sales (Units) of Key Manufacturers (2021–2026)
 Table 7. Global Transcutaneous Jaundice Device Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Transcutaneous Jaundice Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Transcutaneous Jaundice Device Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Transcutaneous Jaundice Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Transcutaneous Jaundice Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Transcutaneous Jaundice Device, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Transcutaneous Jaundice Device, Product Types and Applications
 Table 14. Global Key Manufacturers of Transcutaneous Jaundice Device, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Transcutaneous Jaundice Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Transcutaneous Jaundice Device Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Transcutaneous Jaundice Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Transcutaneous Jaundice Device Sales by Region (Units), 2021–2026
 Table 20. Global Transcutaneous Jaundice Device Sales Market Share by Region (2021–2026)
 Table 21. Global Transcutaneous Jaundice Device Sales by Region (Units), 2027–2032
 Table 22. Global Transcutaneous Jaundice Device Sales Market Share by Region (2027–2032)
 Table 23. Global Transcutaneous Jaundice Device Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Transcutaneous Jaundice Device Revenue Market Share by Region (2021–2026)
 Table 25. Global Transcutaneous Jaundice Device Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Transcutaneous Jaundice Device Revenue Market Share by Region (2027–2032)
 Table 27. North America Transcutaneous Jaundice Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Transcutaneous Jaundice Device Sales by Country (Units), 2021–2026
 Table 29. North America Transcutaneous Jaundice Device Sales by Country (Units), 2027–2032
 Table 30. North America Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Transcutaneous Jaundice Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Transcutaneous Jaundice Device Sales by Country (Units), 2021–2026
 Table 34. Europe Transcutaneous Jaundice Device Sales by Country (Units), 2027–2032
 Table 35. Europe Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Transcutaneous Jaundice Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Transcutaneous Jaundice Device Sales by Region (Units), 2021–2026
 Table 39. Asia Pacific Transcutaneous Jaundice Device Sales by Region (Units), 2027–2032
 Table 40. Asia Pacific Transcutaneous Jaundice Device Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Transcutaneous Jaundice Device Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Transcutaneous Jaundice Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Transcutaneous Jaundice Device Sales by Country (Units), 2021–2026
 Table 44. Latin America Transcutaneous Jaundice Device Sales by Country (Units), 2027–2032
 Table 45. Latin America Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Transcutaneous Jaundice Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Transcutaneous Jaundice Device Sales by Country (Units), 2021–2026
 Table 49. Middle East and Africa Transcutaneous Jaundice Device Sales by Country (Units), 2027–2032
 Table 50. Middle East and Africa Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Transcutaneous Jaundice Device Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Transcutaneous Jaundice Device Sales (Units) by Type (2021–2026)
 Table 53. Global Transcutaneous Jaundice Device Sales (Units) by Type (2027–2032)
 Table 54. Global Transcutaneous Jaundice Device Sales Market Share by Type (2021–2026)
 Table 55. Global Transcutaneous Jaundice Device Sales Market Share by Type (2027–2032)
 Table 56. Global Transcutaneous Jaundice Device Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Transcutaneous Jaundice Device Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Transcutaneous Jaundice Device Revenue Market Share by Type (2021–2026)
 Table 59. Global Transcutaneous Jaundice Device Revenue Market Share by Type (2027–2032)
 Table 60. Global Transcutaneous Jaundice Device Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Transcutaneous Jaundice Device Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Transcutaneous Jaundice Device Sales (Units) by Application (2021–2026)
 Table 63. Global Transcutaneous Jaundice Device Sales (Units) by Application (2027–2032)
 Table 64. Global Transcutaneous Jaundice Device Sales Market Share by Application (2021–2026)
 Table 65. Global Transcutaneous Jaundice Device Sales Market Share by Application (2027–2032)
 Table 66. Global Transcutaneous Jaundice Device Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Transcutaneous Jaundice Device Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Transcutaneous Jaundice Device Revenue Market Share by Application (2021–2026)
 Table 69. Global Transcutaneous Jaundice Device Revenue Market Share by Application (2027–2032)
 Table 70. Global Transcutaneous Jaundice Device Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Transcutaneous Jaundice Device Price (US$/Unit) by Application (2027–2032)
 Table 72. Dräger Company Information
 Table 73. Dräger Description and Business Overview
 Table 74. Dräger Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Dräger Transcutaneous Jaundice Device Product
 Table 76. Dräger Recent Developments/Updates
 Table 77. Mennen Medical Company Information
 Table 78. Mennen Medical Description and Business Overview
 Table 79. Mennen Medical Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Mennen Medical Transcutaneous Jaundice Device Product
 Table 81. Mennen Medical Recent Developments/Updates
 Table 82. Philips Company Information
 Table 83. Philips Description and Business Overview
 Table 84. Philips Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. Philips Transcutaneous Jaundice Device Product
 Table 86. Philips Recent Developments/Updates
 Table 87. Konica Minolta Company Information
 Table 88. Konica Minolta Description and Business Overview
 Table 89. Konica Minolta Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Konica Minolta Transcutaneous Jaundice Device Product
 Table 91. Konica Minolta Recent Developments/Updates
 Table 92. Beijing M&B Electronic Instruments Company Information
 Table 93. Beijing M&B Electronic Instruments Description and Business Overview
 Table 94. Beijing M&B Electronic Instruments Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Beijing M&B Electronic Instruments Transcutaneous Jaundice Device Product
 Table 96. Beijing M&B Electronic Instruments Recent Developments/Updates
 Table 97. Ningbo David Medical Device Company Information
 Table 98. Ningbo David Medical Device Description and Business Overview
 Table 99. Ningbo David Medical Device Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Ningbo David Medical Device Transcutaneous Jaundice Device Product
 Table 101. Ningbo David Medical Device Recent Developments/Updates
 Table 102. VECH MEDICAL Company Information
 Table 103. VECH MEDICAL Description and Business Overview
 Table 104. VECH MEDICAL Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. VECH MEDICAL Transcutaneous Jaundice Device Product
 Table 106. VECH MEDICAL Recent Developments/Updates
 Table 107. AVI Healthcare Company Information
 Table 108. AVI Healthcare Description and Business Overview
 Table 109. AVI Healthcare Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. AVI Healthcare Transcutaneous Jaundice Device Product
 Table 111. AVI Healthcare Recent Developments/Updates
 Table 112. NEORUBIN (RECOVE GROUP) Company Information
 Table 113. NEORUBIN (RECOVE GROUP) Description and Business Overview
 Table 114. NEORUBIN (RECOVE GROUP) Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. NEORUBIN (RECOVE GROUP) Transcutaneous Jaundice Device Product
 Table 116. NEORUBIN (RECOVE GROUP) Recent Developments/Updates
 Table 117. Dolphin Nanjing electronics Company Information
 Table 118. Dolphin Nanjing electronics Description and Business Overview
 Table 119. Dolphin Nanjing electronics Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. Dolphin Nanjing electronics Transcutaneous Jaundice Device Product
 Table 121. Dolphin Nanjing electronics Recent Developments/Updates
 Table 122. Heal Force Company Information
 Table 123. Heal Force Description and Business Overview
 Table 124. Heal Force Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. Heal Force Transcutaneous Jaundice Device Product
 Table 126. Heal Force Recent Developments/Updates
 Table 127. BIOBASE GROUP Company Information
 Table 128. BIOBASE GROUP Description and Business Overview
 Table 129. BIOBASE GROUP Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. BIOBASE GROUP Transcutaneous Jaundice Device Product
 Table 131. BIOBASE GROUP Recent Developments/Updates
 Table 132. Micro Lab Company Information
 Table 133. Micro Lab Description and Business Overview
 Table 134. Micro Lab Transcutaneous Jaundice Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. Micro Lab Transcutaneous Jaundice Device Product
 Table 136. Micro Lab Recent Developments/Updates
 Table 137. Key Raw Materials Lists
 Table 138. Raw Materials Key Suppliers Lists
 Table 139. Transcutaneous Jaundice Device Distributors List
 Table 140. Transcutaneous Jaundice Device Customers List
 Table 141. Transcutaneous Jaundice Device Market Trends
 Table 142. Transcutaneous Jaundice Device Market Drivers
 Table 143. Transcutaneous Jaundice Device Market Challenges
 Table 144. Transcutaneous Jaundice Device Market Restraints
 Table 145. Research Programs/Design for This Report
 Table 146. Key Data Information from Secondary Sources
 Table 147. Key Data Information from Primary Sources
 Table 148. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Transcutaneous Jaundice Device
 Figure 2. Global Transcutaneous Jaundice Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Transcutaneous Jaundice Device Market Share by Type: 2025 & 2032
 Figure 4. Standard Type Product Picture
 Figure 5. Intelligent Type Product Picture
 Figure 6. Global Transcutaneous Jaundice Device Market Value by Technology (US$ Million), 2021–2032
 Figure 7. Global Transcutaneous Jaundice Device Market Share by Technology: 2025 vs 2032
 Figure 8. Single Measurement Optical Path Product Picture
 Figure 9. Dual Measurement Optical Path Product Picture
 Figure 10. Global Transcutaneous Jaundice Device Market Value by Power Supply (US$ Million), 2021–2032
 Figure 11. Global Transcutaneous Jaundice Device Market Share by Power Supply: 2025 vs 2032
 Figure 12. Rechargeable Type Product Picture
 Figure 13. Non-rechargeable Type Product Picture
 Figure 14. Global Transcutaneous Jaundice Device Market Value by Application (US$ Million), 2021–2032
 Figure 15. Global Transcutaneous Jaundice Device Market Share by Application: 2025 & 2032
 Figure 16. Hospitals
 Figure 17. Clinics
 Figure 18. Others
 Figure 19. Global Transcutaneous Jaundice Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Transcutaneous Jaundice Device Market Size (US$ Million), 2021–2032
 Figure 21. Global Transcutaneous Jaundice Device Sales (Units), 2021–2032
 Figure 22. Global Transcutaneous Jaundice Device Average Price (US$/Unit), 2021–2032
 Figure 23. Transcutaneous Jaundice Device Report Years Considered
 Figure 24. Transcutaneous Jaundice Device Sales Share by Manufacturers in 2025
 Figure 25. Global Transcutaneous Jaundice Device Revenue Share by Manufacturers in 2025
 Figure 26. Top 5 and Top 10 Global Transcutaneous Jaundice Device Players: Market Share by Revenue in Transcutaneous Jaundice Device in 2025
 Figure 27. Transcutaneous Jaundice Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 28. Global Transcutaneous Jaundice Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 29. North America Transcutaneous Jaundice Device Sales Market Share by Country (2021–2032)
 Figure 30. North America Transcutaneous Jaundice Device Revenue Market Share by Country (2021–2032)
 Figure 31. United States Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Canada Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Europe Transcutaneous Jaundice Device Sales Market Share by Country (2021–2032)
 Figure 34. Europe Transcutaneous Jaundice Device Revenue Market Share by Country (2021–2032)
 Figure 35. Germany Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. France Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. U.K. Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Italy Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Russia Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Asia Pacific Transcutaneous Jaundice Device Sales Market Share by Region (2021–2032)
 Figure 41. Asia Pacific Transcutaneous Jaundice Device Revenue Market Share by Region (2021–2032)
 Figure 42. China Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Japan Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. South Korea Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. India Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Australia Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. China Taiwan Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Southeast Asia Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Latin America Transcutaneous Jaundice Device Sales Market Share by Country (2021–2032)
 Figure 50. Latin America Transcutaneous Jaundice Device Revenue Market Share by Country (2021–2032)
 Figure 51. Mexico Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Brazil Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Argentina Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Middle East and Africa Transcutaneous Jaundice Device Sales Market Share by Country (2021–2032)
 Figure 55. Middle East and Africa Transcutaneous Jaundice Device Revenue Market Share by Country (2021–2032)
 Figure 56. Turkey Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Saudi Arabia Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. UAE Transcutaneous Jaundice Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Global Sales Market Share of Transcutaneous Jaundice Device by Type (2021–2032)
 Figure 60. Global Revenue Market Share of Transcutaneous Jaundice Device by Type (2021–2032)
 Figure 61. Global Transcutaneous Jaundice Device Price (US$/Unit) by Type (2021–2032)
 Figure 62. Global Sales Market Share of Transcutaneous Jaundice Device by Application (2021–2032)
 Figure 63. Global Revenue Market Share of Transcutaneous Jaundice Device by Application (2021–2032)
 Figure 64. Global Transcutaneous Jaundice Device Price (US$/Unit) by Application (2021–2032)
 Figure 65. Transcutaneous Jaundice Device Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS